Advanced Therapy medicinal products for autologous chondrocytes and comparison of regulatory systems in target countries

Advanced Therapy medicinal products for autologous chondrocytes and comparison of regulatory systems in target countries

Introduction: Autologous chondrocytes (ACs) are Human cell/tissue-based products used for the treatment of joint cartilage defects. Regulatory agencies have established regulations related to ACs to ensure their safety and efficacy. This study investigated the status and characteristics of ACs appro...

Full description

Bibliographic Details
Main Authors:	Kim, E. (Author), Kim, J. (Author), Park, J. (Author), Song, S.-Y (Author)
Format:	Article
Language:	English
Published:	Japanese Society of Regenerative Medicine 2022
Subjects:	Advanced therapy medicinal products ATMPs Autologous chondrocytes HCT/Ps
Online Access:	View Fulltext in Publisher

Similar Items

An ex vivo human cartilage repair model to evaluate the potency of a cartilage cell transplant
by: Christoph Bartz, et al.
Published: (2016-11-01)

Arthroscopic autologous chondrocyte implantation in the hip for the treatment of full-thickness cartilage defects
by: Thier Steffen, et al.
Published: (2017-01-01)

Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP)
by: Zscharnack, Matthias, et al.
Published: (2015)

Long-Term Results of Surgical Treatment for Herniated Discs Using the Technique of Autologous Chondrocyte Transplantation
by: E.G. Pedachenko, et al.
Published: (2016-08-01)

Similar regeneration of articular cartilage defects with autologous & allogenic chondrocytes in a rabbit model
by: P R.J.V.C. Boopalan, et al.
Published: (2019-01-01)

Study on human chondrocyte culture viability for autologous transplantation in clinical application
by: Christiane Lombello, et al.
Published: (2003-06-01)

Regenerative Medicine: A Review of the Evolution of Autologous Chondrocyte Implantation (ACI) Therapy
by: Rebecca L Davies, et al.
Published: (2019-03-01)

Role of Matrix-Associated Autologous Chondrocyte Implantation with Spheroids in the Treatment of Large Chondral Defects in the Knee: A Systematic Review
by: Lucienne Angela Vonk, et al.
Published: (2021-07-01)

Salidroside enhances proliferation and maintains phenotype of articular chondrocytes for autologous chondrocyte implantation (ACI) via TGF-β/Smad3 Signal
by: Miao Sun, et al.
Published: (2020-02-01)

Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19
by: Loubna Mazini, et al.
Published: (2021-01-01)

Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework
by: Marina López-Paniagua, et al.
Published: (2021-03-01)

Comprehensive high-resolution genomic profiling and cytogenetics of human chondrocyte cultures by GTG-banding, locus-specific FISH, SKY and SNP array
by: M Wallenborn, et al.
Published: (2018-04-01)

Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
by: Charlotte H. Hulme, et al.
Published: (2017-06-01)

Non-clinical assessment design of autologous chondrocyte implantation products
by: Taisuke Ikawa, et al.
Published: (2015-06-01)

Transplante autólogo de condrócitos: relato de três casos Autologous chondrocyte implantation: series of 3 cases
by: Riccardo Gomes Gobbi, et al.
Published: (2010-01-01)

A-674563 increases chondrocyte marker expression in cultured chondrocytes by inhibiting Sox9 degradation
by: Kobayashi, Tomohito
Published: (2018)

Clinical evaluation after matrix-associated autologous chondrocyte transplantation: a comparison of four different graft types
by: Harald Binder, et al.
Published: (2021-06-01)

Clinical outcome is significantly better with spheroid-based autologous chondrocyte implantation manufactured with more stringent cell culture criteria
by: C. Eschen, et al.
Published: (2020-03-01)

Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic Strategies
by: Roya Ramezankhani, et al.
Published: (2020-12-01)

From Single Batch to Mass Production–Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product
by: Sebastian Haeusner, et al.
Published: (2021-08-01)

Examination of Knee Isokinetic Strength and Single-Leg Balance of Operated and Non-Operated Side of Patients with Unilateral Matrix-Induced Autologous Chondrocyte Implantation (MACI) Surgery : Pilot Study
by: Çağlar Soylu, et al.
Published: (2017-09-01)

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes
by: Yuzhao Huang, et al.
Published: (2021-04-01)

Platelet-Rich Plasma Supports Proliferation and Redifferentiation of Chondrocytes during In Vitro Expansion
by: Vivek Jeyakumar, et al.
Published: (2017-12-01)

Arthroscopy versus mini-arthrotomy approach for matrix-induced autologous chondrocyte implantation in the knee: a systematic review
by: Filippo Migliorini, et al.
Published: (2021-06-01)

High-Density Autologous Chondrocyte Implantation (HD-ACI) in patients with bilateral knee chondral defects
by: Isabel Guillén-Vicente, et al.
Published: (2021-06-01)

Transplante autólogo de condrócitos Autologous chondrocyte implantation
by: Ronald Bispo Barreto, et al.
Published: (2011-01-01)

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
by: Virginia Ronco, et al.
Published: (2021-03-01)

Chondrocyte Culture Parameters for Matrix-Assisted Autologous Chondrocyte Implantation Affect Catabolism and Inflammation in a Rabbit Model
by: Martin Sauerschnig, et al.
Published: (2019-03-01)

Large osteochondral defect in the lateral femoral condyle reconstructed by Atelocollagen-associated autologous chondrocyte implantation combined with anterior cruciate ligament reconstruction
by: Takuma Kaibara, et al.
Published: (2020-07-01)

Advanced Therapy Medicinal Products (ATMP)and exemptions to the Regulation 1394/2007: how confident can we be? An exploratory analysis.
by: Philippe eVan Wilder
Published: (2012-02-01)

Impact of human platelet lysate on the expansion and chondrogenic capacity of cultured human chondrocytes for cartilage cell therapy
by: JG Sykes, et al.
Published: (2018-05-01)

A low percentage of autologous serum can replace bovine serum to engineer human nasal cartilage
by: F Wolf, et al.
Published: (2008-02-01)

Editorial: Clinical Translation and Commercialisation of Advanced Therapy Medicinal Products
by: Ivan Martin, et al.
Published: (2020-12-01)

Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
by: Kazuo Yano, et al.
Published: (2015-06-01)

Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids
by: Bastien Bourdon, et al.
Published: (2021-01-01)

Marine Collagen Hydrolysates Promote Collagen Synthesis, Viability and Proliferation While Downregulating the Synthesis of Pro-Catabolic Markers in Human Articular Chondrocytes
by: Bastien Bourdon, et al.
Published: (2021-04-01)

Correlation between the AMADEUS score and preoperative clinical patient-reported outcome measurements (PROMs) in patients undergoing matrix-induced autologous chondrocyte implantation (MACI)
by: Armin Runer, et al.
Published: (2019-03-01)

RNA Interference and BMP-2 Stimulation Allows Equine Chondrocytes Redifferentiation in 3D-Hypoxia Cell Culture Model: Application for Matrix-Induced Autologous Chondrocyte Implantation
by: Rodolphe Rakic, et al.
Published: (2017-08-01)

The Effect of Autologous Protein Solution on the Inflammatory Cascade in Stimulated Equine Chondrocytes
by: Renata L. Linardi, et al.
Published: (2019-03-01)

Cell therapy medicinal product regulatory framework in Europe and its application for MSC based therapy development
by: Janis eAncans
Published: (2012-08-01)